Rhabdomyolysis associated to combined ezetimibe-statin treatment

被引：4
|
作者：
Leon, M. Piedra [1 ]
Unzueta, M. T. Garcia
Martinez, M. Otero
Senaris, J. A. Amado
机构：
[1] Hosp Univ Marques Valdecilla, Secc Endocrinol, Santander, Spain
[2] Hosp Univ Marques Valdecilla, Serv Analisis Clin, Santander, Spain
来源：
REVISTA CLINICA ESPANOLA | 2007年 / 207卷 / 08期
关键词：
D O I：
10.1157/13108771
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：425 / 426
页数：2
相关论文
共 50 条
  • [41] Economic evaluation of ezetimibe treatment in combination with statin therapy in the United States
    Davies, Glenn M.
    Vyas, Ami
    Baxter, Carl A.
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (07) : 723 - 731
  • [42] Combination of statin and ezetimibe for the treatment of dyslipidemias and the prevention of coronary artery disease
    Genest, Jacques
    CANADIAN JOURNAL OF CARDIOLOGY, 2006, 22 (10) : 863 - 868
  • [43] Self-Resolving Statin-Associated Myopathy with Rhabdomyolysis and Trismus
    Maramattom, Boby Varkey
    NEUROLOGY INDIA, 2022, 70 (04) : 1687 - 1688
  • [44] Addition of ezetimibe to the treatment of type 2 diabetic patients with hyperlipidaemia, uncontrolled with statin treatment
    Martínez-Martín, FJ
    Rosas, HR
    Martinez, IP
    Soriano, P
    Velasco, PLD
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 113 - 114
  • [45] FDA adverse event reports of statin-associated rhabdomyolysis.
    Ardati, A
    Knapp, D
    Lurie, P
    Wolfe, S
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2003, 18 : 226 - 226
  • [46] Achievement of recommended lipid and lipoprotein levels with combined ezetimibe/statin therapy versus statin alone in patients with and without diabetes
    Guyton, John R.
    Betteridge, D. John
    Farnier, Michel
    Leiter, Lawrence A.
    Lin, Jianxin
    Shah, Arvind
    Johnson-Levonas, Amy O.
    Brudi, Philippe
    DIABETES & VASCULAR DISEASE RESEARCH, 2011, 8 (02): : 160 - 172
  • [47] Effect of ezetimibe-statin combination therapy vs. statin monotherapy on coronary atheroma phenotype and lumen stenosis in patients with coronary artery disease: a meta-analysis and trial sequential analysis
    Zhang, Yun-Jing
    Xu, Min
    Duan, Ji-Qiang
    Wang, De-Jin
    Han, Shi-Liang
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [48] Statin-induced rhabdomyolysis
    Schreiber, Donald H.
    Anderson, Thomas R.
    JOURNAL OF EMERGENCY MEDICINE, 2006, 31 (02): : 177 - 180
  • [49] The Effects of Statin Monotherapy and Low-Dose Statin/Ezetimibe on Lipoprotein-Associated Phospholipase A2
    Lee, Sang-Hak
    Kang, Seok-Min
    Park, Sungha
    Jang, Yangsoo
    Chung, Namsik
    Choi, Donghoon
    CLINICAL CARDIOLOGY, 2011, 34 (02) : 108 - 112
  • [50] Ezetimibe [Ezetrol, Vytorin (ezetimibe/simvastatin)] has the potential to cause myopathy or rhabdomyolysis
    Reactions Weekly, 2006, 1128 (1) : 2 - 2
12345